| 期 |
栏目 |
标题 |
文件 |
| 卷 17, 编号 3 (2020) |
Reviews |
Modern view on LRBA deficiency |
(Rus)
|
| 卷 17, 编号 4 (2020) |
Case reports |
A clinical case of the X-linked moesin deficiency |
(Rus)
|
| 卷 19, 编号 1 (2022) |
Original studies |
Hereditary angioedema with C1-inhibitor deficiency: a retrospective study of 194 patients |
(Rus)
(Eng)
|
| 卷 18, 编号 1 (2021) |
Letters to the editor |
Chronic urticaria in theory and practice. Experience of UCARE-centers for clinicians |
(Rus)
(Eng)
|
| 卷 17, 编号 2 (2020) |
Help to the practitioner |
Personalized approach to choice-making of an immunoglobulin for the replacement therapy in patients with primary immunodeficiency - is the way to success. |
(Rus)
(Eng)
|
| 卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination of patients with allergic disease against novel coronavirus infection: position paper of the Russian Association of Allergology and Clinical Immunology |
(Rus)
|
| 卷 18, 编号 3 (2021) |
Clinical practice guidelines |
Vaccination against COVID-19 for patients with primary immunodeficiency and hereditary angioedema: the position paper of the Russian Association of Allergology, Clinical Immunology, and the National Association of Experts in Primary Immunodeficiencies |
(Rus)
|
| 卷 18, 编号 4 (2021) |
Case reports |
Clinical characteristics of chronic spontaneous urticaria in patients with Common variable immune deficiency and hypogammaglobulinemia |
(Rus)
|
| 卷 18, 编号 2 (2021) |
Original studies |
Hereditary Angioedema (HAE) with a mutation in the plasminogen gene: a retrospective study of a cohort of 14 patients from Russia |
(Rus)
(Eng)
|
| 卷 18, 编号 3 (2021) |
Letters to the editor |
Long-term prophylaxis therapy in patients with hereditary angioedema in Russia: resolution of the expert Council |
(Rus)
|
| 卷 19, 编号 3 (2022) |
Original studies |
Study of the silver birchpollen allergoid |
|
| 卷 18, 编号 2 (2021) |
Help to the practitioner |
Hereditary angioedema. Clinical guidelines. (D84.1) |
(Rus)
|
| 卷 18, 编号 2 (2021) |
Case reports |
Challenges of differential diagnosis of mediators-induced and bradykinin-induced angioedema shown by a clinical case series |
(Rus)
|
| 卷 19, 编号 3 (2022) |
Case reports |
Ceftriaxone induced fixed drug eruption in patient with common variable immunodeficiency |
|
| 卷 20, 编号 2 (2023) |
Original studies |
Preliminary results of a non-interventional single-center study evaluating the efficacy of long-term use of lanadelumab in routine clinical practice in the Russian Federation |
(Rus)
(Eng)
|
